Re-Rehabilitation in Chronic Obstrctive Pulmonary Disease

Copd Clinical Trial

Official title:

The Effect of Re-Rehabilitation in Patients With COPD

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04009538
• Other study ID #: IzmirKCU1
• Status: Completed
• Phase: N/A
• Start date: January 2013
• Est. completion date: March 2019

Study information

• Verified date: July 2019
• Source: Izmir Katip Celebi University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Patients with COPD who participated in the second rehabilitation program in the Pulmonary Rehabilitation unit will be included in the study. Pulmonary function tests, arterial blood gases, mMRC dyspnea perception, 6-minute walking distance, disease-specific (SGRQ) quality of life and hospital anxiety depression scale values will be compared.

Description:

Pulmonary rehabilitation (PR) program in patients with COPD reduces dyspnea perception, increases exercise capacity, improves quality of life, and reduces psychological symptoms. Unfortunately, these gains are not permanent, but disappear within 12-24 months. The aim of this study is to compare the gains of the second PR program with the first program.

Patients with COPD who participated in the second rehabilitation program in the Pulmonary Rehabilitation unit will be included in the study. Pulmonary function tests, arterial blood gases, mMRC dyspnea perception, 6-minute walking distance, disease-specific (SGRQ) quality of life and hospital anxiety depression scale values will be compared.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 22
• Est. completion date: March 2019
• Est. primary completion date: March 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Above 18 years

• Completed PR program

Exclusion Criteria:

-

Related Conditions & MeSH terms

• Copd
• Rehabilitation; Tobacco Use
• Smoking
• Smoking Cessation

Intervention

Other:
• Rehabilitation program
exercise program twice a week

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Izmir Katip Celebi University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Exercise Capacity	Six minutes walk test	6 minutes
Secondary	Respiratory Functions	Pulmonary Function Test	30 minutes
Secondary	Dyspnea Sensation	We used "Modified Medical Research Council (MMRC)" dyspnea scale, which consists of 5 items ranging between 1 and 5, to determine the severity of patients' shortness of breath. The score "1" represents the best level, where the score "5" indicates the poorest.	5 minutes
Secondary	Disease Specific Quality of Life	We used St. George's Respiratory Questionnaire (SGRQ) to determine disease-specific quality of life. At this scale, high scores define worsened disease and increased symptoms.	20 minutes
Secondary	Anxiety and Depression	Hospital Anxiety and Depression (HAD) Inventory was used for assessment of anxiety and depression. In this scale; scores of anxiety and depression are calculated separately. The maximum score for both is 21 and high scores correspond to high degree anxiety and depression. Cut-off scores for anxiety and depression were determined as 10/11 and 7/8 respectively.	20 minutes